Successful deceased donor renal transplant in a sensitized pediatric recipient with the use of plasmapheresis

Pediatric Transplantation

Volumn 12, Issue 6, 2008, Pages 711-716

  Pradhan, Madhura ^a,b   Raffaelli, Ryan M ^b   Lind, Curt ^b   Meyers, Kevin E C ^b   Kaplan, Bernard S ^b   Baluarte, Hobart J ^b   Monos, Dimitri ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Deceased donor kidney; Desensitization; Highly sensitized; Intravenous immunoglobulin; Kidney; Plasmapheresis; Renal transplantation; Rituximab

Indexed keywords

ANTIGEN; HLA ANTIBODY; IMMUNOGLOBULIN; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ANALYTIC METHOD; ANTIBODY TITER; ARTICLE; CASE REPORT; CONTROLLED STUDY; DESENSITIZATION; DRUG MEGADOSE; FEMALE; FLOW CYTOMETRY; HUMAN; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; MONITORING; PATIENT COMPLIANCE; PLASMAPHERESIS; RECIPIENT; SCHOOL CHILD; SENSITIZATION;

ANTIBODIES, MONOCLONAL; CHILD; FEMALE; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOGLOBULINS; IMMUNOPHENOTYPING; INFUSIONS, INTRAVENOUS; KIDNEY; KIDNEY TRANSPLANTATION; PEDIATRICS; PLASMAPHERESIS; THROMBOSIS; TISSUE AND ORGAN PROCUREMENT;

EID: 49349094692     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.00938.x     Document Type: Article

References (21)

1. OPTN/SRTR. Annual Report, 2004. Available at: http://www.ustransplant. org. Accessed 14 February 2008.
2. Tyan DB, Li VA, Czer L, Trento A, Jordan SC. Intravenous immunoglobulin suppression of HLA alloantibodies in highly sensitized transplant candidates and transplantation with a histoincompatible organ. Transplantation 1994: 57: 553 562.
3. Jordan SC, Vo A, Bunnapradist S, et al. Intravenous immunoglobulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaveric recipients. Transplantation 2003: 76: 631 636.
4. Jordan SC, Tyan D, Stablein D, et al. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly-HLA sensitized adult patients with end stage renal disease: Report of the NIH IGO2 trial. J Am Soc Nephrol 2004: 15: 3256 3262.
5. Glotz D, Antoine C, Julia P, et al. Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg). Am J Transplant 2002: 2: 758 760.
6. Montgomery RA, Zachary AA, Racusen LC, et al. Plasmapheresis and intravenous inmmune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into crossmatch-positive recipients. Transplantation 2000: 70: 887 895.
7. Gloor JM, DeGoey SR, Pineda AA, et al. Overcoming a positive crossmatch in living-donor kidney transplantation. Am J Transplant 2003: 3: 1017 1023.
8. Schweitzer EJ, Wilson JS, Fernandez-Vina M, et al. A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants. Transplantation 2000: 70: 1531 1536.
9. Montgomery RA, Zachary AA. Transplanting patients with a positive donor-specific crossmatch: A single center's perspective. Pediatr Transplant 2004: 8: 535 542.
10. Rodey GE, Neylan JF, Whelchel JD, Revels KW, Bray RA. Epitope specificity of HLA Class I alloantibodies: I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients. Hum Immunol 1994: 39: 272 280.
11. Zachary AA, Hart J. Relevance of antibody screening and crossmatch tests for solid organ transplantation. In: Donnenberg AD, Leffell MS, Rose NR, eds. CRC Handbook of Human Immunology. Boca Raton, FL: CRC Press Inc, 1997: pp. 47 519.
12. Falk JA, Cardella CJ, Halloran PF, Bear RA, Arbus GS. Graft outcome in the multiple transplant patient with a positive donor cross-match with non-current sera. Transplant Proc 1987: 19: 721 722.
13. Cardella CJ, Falk JA, Nicholson MJ, Harding M, Cook GT. Successful renal transplantation in patients with T-cell reactivity to donor. Lancet 1982: 2: 1240 1243.
14. Noreen HJ, McKinley DM, Gillingham KJ, Matas AJ, Segall M. Positive remote crossmatch: Impact on short-term and long-term outcome in cadaver renal transplantation. Transplantation 2003: 75: 501 505.
15. Cho YW, Cecka JM. Cross-match tests- an analysis of UNOS data from 1991 to 2000. In: Terasaki C, ed. Clinical Transplants. Los Angeles, CA: UCLA Immunogenetics Center, 2001: pp. 237 246.
16. Stegall MD, Gloor J, Winters JL, Moore SB, DeGoey S. A comparison of plasmapheresis versus high-dose IVIg desensitization in renal allograft recipients with high levels of donor specific alloantibody. Am J Transplant 2006: 6: 346 351.
17. Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2000: 345: 747 755.
18. Silverman GJ, Weisman S. Rituximab therapy and autoimmune disorders. Arth Rheum 2003: 48: 1484 1492.
19. Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002: 62: 311 318.
20. Salvadori M, Rosati A, Bock A, et al. One-year posttransplant renal function is a strong predictor of long-term kidney function: Results from the Neoral-MOST Observational Study. Transplant Proc 2003: 35: 2863 2867.
21. Salvadori M, Rosati A, Bock A, et al. Estimated one-year glomerular filtration rate is the best predictor of long-term graft function following renal transplant. Transplantation 2006: 81: 202 206.